Maraviroc Tablet, Film Coated
Product Images NDC 68475-008

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Maraviroc (NDC 68475-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9623d31f 0856 4aca A288 C542b28edfba 01)

Chemical structure of maraviroc, showing the detailed molecular arrangement including fluorine atoms, phenyl ring, and piperazine moiety represented in standard chemical notation.*

FDA Label Image

Pdp-150mg (9623d31f 0856 4aca A288 C542b28edfba 02)

Label for Maraviroc Tablets 150 mg oral film-coated tablets, 60 count, manufactured for Navinta LLC. The label includes a barcode, storage instructions (20°C to 25°C), and a warning not to use if the printed safety seal is broken or missing. It states the product is made in India and includes the manufacturer's address in Ewing, NJ.*

FDA Label Image

Pdp-300mg (9623d31f 0856 4aca A288 C542b28edfba 03)

Label for Maraviroc 300 mg film-coated tablets, showing a quantity of 60 tablets. The label indicates the product is prescription only, manufactured for Navinta LLC in Ewing, NJ, and made in India. It includes storage instructions, a barcode, and a warning not to use if the safety seal under the cap is broken or missing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.